Falco A et al. |
Inhibition of thromboxane biosynthesis by triflusal in type 2 diabetes mellitus. |
2005 |
Atherosclerosis |
pmid:16285996
|
Markuszewski L et al. |
Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin? |
2006 |
Basic Clin. Pharmacol. Toxicol. |
pmid:16635110
|
Calapai G et al. |
Cardiovascular biomarkers in groups of established smokers after a decade of smoking. |
2009 |
Basic Clin. Pharmacol. Toxicol. |
pmid:19175368
|
Liu TF et al. |
[Correlation between the level of the urinary 11-dehydrothromboxane B2 and the clinical efficacy of aspirin in patients with type 2 diabetes and coronary artery disease]. |
2015 |
Beijing Da Xue Xue Bao |
pmid:26679651
|
Varma D et al. |
Comparison of UHPLC and HPLC methods for the assay of prostanoids: "are the methods equivalent in terms of accuracy and precision?". |
2011 |
Bioanalysis |
pmid:21510759
|
Ciabattoni G et al. |
Fractional conversion of thromboxane B2 to urinary 11-dehydrothromboxane B2 in man. |
1989 |
Biochim. Biophys. Acta |
pmid:2752040
|
Patrignani P et al. |
Fractional conversion of thromboxane A2 and B2 to urinary 2,3-dinor-thromboxane B2 and 11-dehydrothromboxane B2 in the cynomolgus monkey. |
1989 |
Biochim. Biophys. Acta |
pmid:2752041
|
Wu P et al. |
Purification and characterization of an NAD(+)-dependent dehydrogenase that catalyzes the oxidation of thromboxane B2 at C-11 from porcine liver. Development and application of 11-dehydro-thromboxane B2 radioimmunoassay to enzyme assay. |
1990 |
Biochim. Biophys. Acta |
pmid:2223826
|
Lorenz RL et al. |
A critical evaluation of urinary immunoreactive thromboxane: feasibility of its determination as a potential vascular risk indicator. |
1989 |
Biochim. Biophys. Acta |
pmid:2597697
|
Ciabattoni G et al. |
Radioimmunoassay of 11-dehydrothromboxane B2 in human plasma and urine. |
1987 |
Biochim. Biophys. Acta |
pmid:3567215
|